Company intelligence / Profile preview

AnaMar

Lund, Skåne län, Swedenanamar.com ↗

Ownership: Private
Development stage: Phase 2

Overview

AnaMar is a clinical-stage Swedish biotech developing first-in-class, orally available anti-fibrotic medicines targeting the serotonin 5‑HT2B receptor. Its lead candidate, AM1476, has completed Phase I with established pharmacokinetic and safety profiles and has received orphan drug designation from both the FDA and EMA for systemic sclerosis. A Phase II trial in SSc–ILD is planned. The company’s approach aims to halt or reverse fibrosis in both skin and lung tissue—a significant unmet need in systemic sclerosis treatment.

Therapeutic areas: ImmunologyDermatologyRheumatology
Modalities: Small molecules (specifically, orally bioavailable 5-HT2B receptor antagonists)
Industry: Biotech

Drug pipeline

3 assets

AM1030

2 more assets in the full pipeline.

Request access →

Partnerships

Currently seeking pharma partners for advancement of lead program into late-stage trials/commercialization; no major partnerships disclosed yet.

Beyond the preview

Go deeper on AnaMar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AnaMar.

Explore the full profile